Effects	effects	O	O	O	O
of	of	O	O	O	O
aminophylline	aminophylline	CHEMICALS	O	OTHERS	I
on	on	O	O	O	O
the	the	O	O	O	O
threshold	threshold	O	O	O	O
for	for	O	O	O	O
initiating	initiating	O	O	O	O
ventricular	ventricular	O	DISEASE	OTHERS	I
fibrillation	fibrillation	O	DISEASE	OTHERS	I
during	during	O	O	O	O
respiratory	respiratory	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Cardiac	cardiac	O	DISEASE	OTHERS	I
arrhythmias	arrhythmias	O	DISEASE	OTHERS	I
have	have	O	O	O	O
frequently	frequently	O	O	O	O
been	been	O	O	O	O
reported	reported	O	O	O	O
in	in	O	O	O	O
association	association	O	O	O	O
with	with	O	O	O	O
respiratory	respiratory	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
possible	possible	O	O	O	O
additive	additive	O	O	O	O
role	role	O	O	O	O
of	of	O	O	O	O
pharmacologic	pharmacologic	O	O	O	O
agents	agents	O	O	O	O
in	in	O	O	O	O
precipitating	precipitating	O	O	O	O
cardiac	cardiac	O	O	OTHERS	I
disturbances	disturbances	O	O	OTHERS	I
in	in	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
respiratory	respiratory	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
has	has	O	O	O	O
only	only	O	O	O	O
recently	recently	O	O	O	O
been	been	O	O	O	O
emphasized	emphasized	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
aminophylline	aminophylline	CHEMICALS	O	OTHERS	I
on	on	O	O	O	O
the	the	O	O	O	O
ventricular	ventricular	O	DISEASE	OTHERS	I
fibrillation	fibrillation	O	DISEASE	OTHERS	I
threshold	threshold	O	O	O	O
during	during	O	O	O	O
normal	normal	O	O	O	O
acid-base	acid-base	O	O	O	O
conditions	conditions	O	O	O	O
and	and	O	O	O	O
during	during	O	O	O	O
respiratory	respiratory	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
were	were	O	O	O	O
studied	studied	O	O	O	O
in	in	O	O	O	O
anesthetized	anesthetized	O	O	O	O
open	open	O	O	O	O
chest	chest	O	O	O	O
dogs	dogs	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
ventricular	ventricular	O	DISEASE	OTHERS	I
fibrillation	fibrillation	O	DISEASE	OTHERS	I
threshold	threshold	O	O	O	O
was	was	O	O	O	O
measured	measured	O	O	O	O
by	by	O	O	O	O
passing	passing	O	O	O	O
a	a	O	O	O	O
gated	gated	O	O	O	O
train	train	O	O	O	O
of	of	O	O	O	O
12	12	O	O	O	O
constant	constant	O	O	O	O
current	current	O	O	O	O
pulses	pulses	O	O	O	O
through	through	O	O	O	O
the	the	O	O	O	O
ventricular	ventricular	O	O	O	O
myocardium	myocardium	O	O	O	O
during	during	O	O	O	O
the	the	O	O	O	O
vulnerable	vulnerable	O	O	O	O
period	period	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
cardiac	cardiac	O	O	O	O
cycle	cycle	O	O	O	O
.	.	O	O	O	O

During	during	O	O	O	O
the	the	O	O	O	O
infusion	infusion	O	O	O	O
of	of	O	O	O	O
aminophylline	aminophylline	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
the	the	O	O	O	O
ventricular	ventricular	O	DISEASE	OTHERS	I
fibrillation	fibrillation	O	DISEASE	OTHERS	I
threshold	threshold	O	O	O	O
was	was	O	O	O	O
reduced	reduced	O	O	O	O
by	by	O	O	O	O
30	30	O	O	O	O
to	to	O	O	O	O
40	40	O	O	O	O
percent	percent	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
control	control	O	O	O	O
when	when	O	O	O	O
pH	ph	O	O	O	O
and	and	O	O	O	O
partial	partial	O	O	O	O
pressures	pressures	O	O	O	O
of	of	O	O	O	O
oxygen	oxygen	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
PO2	po2	O	O	OTHERS	I
)	)	O	O	O	O
and	and	O	O	O	O
carbon	carbon	CHEMICALS	O	OTHERS	I
dioxide	dioxide	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
CO2	co2	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
were	were	O	O	O	O
kept	kept	O	O	O	O
within	within	O	O	O	O
normal	normal	O	O	O	O
limits	limits	O	O	O	O
.	.	O	O	O	O

When	when	O	O	O	O
respiratory	respiratory	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
was	was	O	O	O	O
produced	produced	O	O	O	O
by	by	O	O	O	O
hypoventilation	hypoventilation	O	O	OTHERS	I
(	(	O	O	O	O
pH	ph	O	O	O	O
7.05	7.05	O	O	O	O
to	to	O	O	O	O
7.25	7.25	O	O	O	O
;	;	O	O	O	O
PC02	pc02	O	O	O	O
70	70	O	O	O	O
to	to	O	O	O	O
100	100	O	O	O	O
mm	mm	O	O	OTHERS	I
Hg	hg	O	O	OTHERS	I
:	:	O	O	O	O
P02	p02	O	O	O	O
20	20	O	O	O	O
to	to	O	O	O	O
40	40	O	O	O	O
mm	mm	O	O	OTHERS	I
Hg	hg	O	O	OTHERS	I
)	)	O	O	O	O
,	,	O	O	O	O
infusion	infusion	O	O	O	O
of	of	O	O	O	O
aminophylline	aminophylline	CHEMICALS	O	OTHERS	I
resulted	resulted	O	O	O	O
in	in	O	O	O	O
an	an	O	O	O	O
even	even	O	O	O	O
greater	greater	O	O	O	O
decrease	decrease	O	O	O	O
in	in	O	O	O	O
ventricular	ventricular	O	DISEASE	OTHERS	I
fibrillation	fibrillation	O	DISEASE	OTHERS	I
threshold	threshold	O	O	O	O
to	to	O	O	O	O
60	60	O	O	O	O
percent	percent	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
control	control	O	O	O	O
level	level	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
experiments	experiments	O	O	O	O
suggest	suggest	O	O	O	O
that	that	O	O	O	O
although	although	O	O	O	O
many	many	O	O	O	O
factors	factors	O	O	O	O
may	may	O	O	O	O
contribute	contribute	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
increased	increased	O	O	O	O
incidence	incidence	O	O	O	O
of	of	O	O	O	O
ventricular	ventricular	O	DISEASE	OTHERS	I
arrhythmias	arrhythmias	O	DISEASE	OTHERS	I
in	in	O	O	O	O
respiratory	respiratory	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
,	,	O	O	O	O
pharmacologic	pharmacologic	O	O	O	O
agents	agents	O	O	O	O
,	,	O	O	O	O
particularly	particularly	O	O	O	O
aminophylline	aminophylline	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
may	may	O	O	O	O
play	play	O	O	O	O
a	a	O	O	O	O
significant	significant	O	O	O	O
role	role	O	O	O	O
.	.	O	O	O	O

